These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33371334)

  • 21. Topical delivery of 3,5,4'-trimethoxy-trans-stilbene-loaded microemulsion-based hydrogel for the treatment of osteoarthritis in a rabbit model.
    Hu XB; Kang RR; Tang TT; Li YJ; Wu JY; Wang JM; Liu XY; Xiang DX
    Drug Deliv Transl Res; 2019 Feb; 9(1):357-365. PubMed ID: 30430453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: preparation, optimization, and evaluation.
    Zhao L; Wang Y; Zhai Y; Wang Z; Liu J; Zhai G
    Int J Pharm; 2014 Dec; 477(1-2):47-56. PubMed ID: 25304092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine laden tailored microemulsion-gel depot for effective treatment of psoriasis: In vitro and in vivo studies.
    Pandey SS; Maulvi FA; Patel PS; Shukla MR; Shah KM; Gupta AR; Joshi SV; Shah DO
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110681. PubMed ID: 31812077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation evaluation of ketoconazole microemulsion-loaded hydrogel with nigella oil as a penetration enhancer.
    Amra K; Momin M
    J Cosmet Dermatol; 2019 Dec; 18(6):1742-1750. PubMed ID: 30980617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
    Palfreeman AC; McNamee KE; McCann FE
    Drug Des Devel Ther; 2013; 7():201-10. PubMed ID: 23569359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacodynamic impact of apremilast, an oral phosphodiesterase 4 inhibitor, on circulating levels of inflammatory biomarkers in patients with psoriatic arthritis: substudy results from a phase III, randomized, placebo-controlled trial (PALACE 1).
    Schafer PH; Chen P; Fang L; Wang A; Chopra R
    J Immunol Res; 2015; 2015():906349. PubMed ID: 25973439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apremilast effectively inhibits TNFα-induced vascular inflammation in human endothelial cells.
    Otto M; Dorn B; Grasmik T; Doll M; Meissner M; Jakob T; Hrgovic I
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):237-246. PubMed ID: 34699634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microemulsion-Based Topical Hydrogels of Tenoxicam for Treatment of Arthritis.
    Goindi S; Narula M; Kalra A
    AAPS PharmSciTech; 2016 Jun; 17(3):597-606. PubMed ID: 26285672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and evaluation of microemulsion-based hydrogel for topical delivery.
    Sabale V; Vora S
    Int J Pharm Investig; 2012 Jul; 2(3):140-9. PubMed ID: 23373005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chitosan coating on microemulsion for effective dermal clotrimazole delivery.
    Kumari B; Kesavan K
    Pharm Dev Technol; 2017 Jun; 22(4):617-626. PubMed ID: 27574791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.
    Bianchi L; Del Duca E; Romanelli M; Saraceno R; Chimenti S; Chiricozzi A
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1121-8. PubMed ID: 27376729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial.
    Ohtsuki M; Okubo Y; Komine M; Imafuku S; Day RM; Chen P; Petric R; Maroli A; Nemoto O
    J Dermatol; 2017 Aug; 44(8):873-884. PubMed ID: 28391657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microemulsion loaded hydrogel as a promising vehicle for dermal delivery of the antifungal sertaconazole: design, optimization and ex vivo evaluation.
    Radwan SAA; ElMeshad AN; Shoukri RA
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1351-1365. PubMed ID: 28420288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microemulsion for topical application of pentoxifylline: In vitro release and in vivo evaluation.
    Cavalcanti AL; Reis MY; Silva GC; Ramalho ÍM; Guimarães GP; Silva JA; Saraiva KL; Damasceno BP
    Int J Pharm; 2016 Jun; 506(1-2):351-60. PubMed ID: 27130362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
    Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S
    Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast.
    Chiricozzi A; Caposiena D; Garofalo V; Cannizzaro MV; Chimenti S; Saraceno R
    Expert Rev Clin Immunol; 2016; 12(3):237-49. PubMed ID: 26692125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.
    Ge S; Lin Y; Lu H; Li Q; He J; Chen B; Wu C; Xu Y
    Int J Pharm; 2014 Apr; 465(1-2):120-31. PubMed ID: 24530389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal delivery enhancement of carvacrol from Origanum vulgare L. essential oil by microemulsion.
    Laothaweerungsawat N; Neimkhum W; Anuchapreeda S; Sirithunyalug J; Chaiyana W
    Int J Pharm; 2020 Apr; 579():119052. PubMed ID: 31982557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and Evaluation of Azelaic Acid Topical Microemulsion Formulation: In Vitro and In Vivo Study.
    Hung WH; Chen PK; Fang CW; Lin YC; Wu PC
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.